For breast cancer, KNTc-gD:GDNF retargeted GFRα1 by replacing the gD signal peptide and HVEM-binding domain with pre-pro-GDNF and deleting aa 38 to prevent nectin-1 binding.125. Here, GFRA1 is linked to breast cancer.